Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy
- 22 April 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 129 (16) , 1629-1636
Abstract
Background—: Although primary percutaneous coronary intervention (pPCI) is the preferred reperfusion method for ST-segment–elevation myocardial infarction, it remains difficult to implement in many areas, and fibrinolytic therapy is still widely used. Methods and Results—: We assessed 5-year mortality in patients with ST-segment–elevation myocardial infarction from the French Registry of Acute ST-Elevation or Non-ST Elevation Myocardial Infarction (FAST-MI) 2005 according to use and type of reperfusion therapy. Of 1492 patients with ST-segment–elevation myocardial infarction with a first call ≤12 hours from onset, 447 (30%) received fibrinolysis (66% prehospital; 97% with subsequent angiography, 84% with subsequent PCI), 583 (39%) had pPCI, and 462 (31%) received no reperfusion. Crude 5-year survival was 88% for the fibrinolytic-based strategy, 83% for pPCI, and 59% for no reperfusion. Adjusted hazard ratios for 5-year death were 0.73 (95% confidence interval, 0.50–1.06) for fibrinolysis versus pPCI, 0.57 (95% confidence interval, 0.36–0.88) for prehospital fibrinolysis versus pPCI, and 0.63 (95% confidence interval, 0.34–0.91) for fibrinolysis versus pPCI beyond 90 minutes of call in patients having called ≤180 minutes from onset. In propensity score–matched populations, however, survival rates were not significantly different for fibrinolysis and pPCI, both in the whole population (88% lysis, 85% pPCI) and in the population seen early (87% fibrinolysis, 85% pPCI beyond 90 minutes from call). Conclusions—: In a real-world setting, on a nationwide scale, a pharmaco-invasive strategy constitutes a valid alternative to pPCI, with 5-year survival at least equivalent to that of the reference reperfusion method. Clinical Trial Registration—: URL: www.clinicaltrials.gov . Unique identifier: NCT00673036.Keywords
This publication has 19 references indexed in Scilit:
- Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial InfarctionNew England Journal of Medicine, 2013
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryCirculation, 2013
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2012
- Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysisEuropean Heart Journal, 2010
- Routine Early Angioplasty after Fibrinolysis for Acute Myocardial InfarctionNew England Journal of Medicine, 2009
- Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial InfarctionCirculation, 2009
- Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial InfarctionCirculation, 2008
- Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trialThe Lancet, 2008
- Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 2005
- Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trialThe Lancet, 2004